>

Child 1 (gender-neutral, stage I obesity, anterior)

Q: Can I use the Child 1 (gender-neutral, stage I obesity, anterior) icon in a BioRender figure or scientific illustration?

Yes — the Child 1 (gender-neutral, stage I obesity, anterior) is fully integrated into BioRender's drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you're building from scratch or starting with a BioRender template.

Q: Can I export figures that include the Child 1 (gender-neutral, stage I obesity, anterior) icon for publication or presentations?

Yes — figures containing the Child 1 (gender-neutral, stage I obesity, anterior) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Child 1 (gender-neutral, stage I obesity, anterior) - Editable icon of a gender-neutral child with stage I obesity in an anterior anatomical position, with White facial features

[{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f074a/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f074a/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f074b/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f074b/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f074c/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f074c/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f074d/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f074d/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f074e/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f074e/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f074f/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f074f/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0750/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0750/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0751/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0751/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0752/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0752/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0753/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0753/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0754/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0754/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0755/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0755/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0756/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0756/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0757/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0757/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0758/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0758/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0759/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0759/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f075a/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f075a/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f075b/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f075b/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f075c/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f075c/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f075d/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f075d/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f075e/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f075e/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f075f/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f075f/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0760/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0760/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0761/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0761/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0762/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0762/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0763/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0763/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0764/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0764/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0765/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0765/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0766/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0766/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0767/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0767/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0768/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0768/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f0769/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f0769/671a98bc1adafe9ee12f0697.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/671a99301adafe9ee12f076a/671a98bc1adafe9ee12f0697.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/671a99301adafe9ee12f076a/671a98bc1adafe9ee12f0697.png"}]

Keywords

keyword text

child,gender-neutral child,child gender neutral,gender-neutral,neutral,asexual,unsexed,sexless,male child,female child,boy child,girl child,boy,girl,young,young age,small child,children,kid,human child,minor,adolescent,preadolescence,preteen,preteenager,tween,tweenager,tweener,overweight,obese,obesity stage I,high BMI,excess weight,large,chubby,plus-sized,heavy,full-figured,above average weight,back,head,limbs,arm,leg,hand,foot,feet,anterior,frontal,front view,anterior view,front,nude,naked,without clothes,unclothed,human,human figure,figure,child development,development,puberty,pediatric,pediatrics,whole body,body,age,person,human anatomy,anatomy,White,Caucasian,European,light-skinned,fair-skinned,Western,Anglo,Euro-American,Nordic,Anglo-Saxon,Slavic,fair complexion,24q2-content-refinement,24q2-content-refinement-human-figure-diversity,child

BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More

More Icons like this one in

Related Categories

Back To Library Home

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today

Sign Up Free

FAQs

What is BioRender?

BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Child 1 (gender-neutral, stage I obesity, anterior) icon along with our library of more than 30,000 life science icons.

Can I use this icon in a BioRender figure or scientific illustration?

Yes, the Child 1 (gender-neutral, stage I obesity, anterior) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.

Is the Child 1 (gender-neutral, stage I obesity, anterior) icon customizable in BioRender?

Most icons in BioRender, including the Child 1 (gender-neutral, stage I obesity, anterior) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.

How are scientists using the Child 1 (gender-neutral, stage I obesity, anterior) icon in their work?

BioRender users often use the Child 1 (gender-neutral, stage I obesity, anterior) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Human Anatomy.

Can I export figures that include the Child 1 (gender-neutral, stage I obesity, anterior) icon for publication or presentations?

Yes, figures containing the Child 1 (gender-neutral, stage I obesity, anterior) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.

Is the Child 1 (gender-neutral, stage I obesity, anterior) icon used in BioRender templates or poster layouts?

Many BioRender templates include icons like the Child 1 (gender-neutral, stage I obesity, anterior) icon — especially those focused on Human Anatomy. You can search BioRender’s template library or add this icon manually to any canvas.

Make scientific figures in minutes

Child 1 (gender-neutral, stage I obesity, anterior)

Join 1,500,000 other scientists on BioRender

FAQs

Looking for science content?